Tissue-specific differential repression of gene expression by a dominant negative mutant of thyroid hormone β1 receptor

Thyroid

Volumn 9, Issue 4, 1999, Pages 411-418

  Bhat, Manoj Kumar ^a   Dace, Alexandra ^a   Cheng, Sheue Yann ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; LIOTHYRONINE; MALATE DEHYDROGENASE (DECARBOXYLATING); RECEPTOR PROTEIN; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN GH3; CONTROLLED STUDY; GENE MUTATION; GENE REPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; THYROID HORMONE RESISTANCE; TISSUE SPECIFICITY;

EID: 0033004238     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.411     Document Type: Article

References (21)

1. Cheng S-y 1995 New insights into the structure and function of the thyroid hormone receptor. J Biomed Sci 2:77-89.
2. Oppenheimer JH, Schwartz HL, Strait KA 1996 In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid: A fundamental and clinical text. 7th ed, Lippincott-Raven, New York, pp 162-184.
3. Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, O'Malley BW 1997 Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52:141-164.
4. Yap N, Yu CL, Cheng S-y 1996 Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53. Proc Natl Acad Sci USA 93:4273-4277.
5. Bhat MK, Yu CL, Yap N, Zhan Q, Hayashi Y, Seth P, Cheng S 1997 Tumor suppressor p53 is a negative regulator in thyroid hormone receptor signaling pathways. J Biol Chem 272:28989-28993.
6. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399.
7. Brucker-Davis F, Skarulis MC, Grace MB, Benichou J, Hauser P, Wiggs E, Weintraub BD 1995 Genetic and clinical features of 42 kindreds with resistance to thyroid hormone: The National Institutes of Health prospective study. Ann Intern Med 123:572-583.
8. Samuels HH, Tsai JS, Cintron R 1973 Thyroid hormone action: A cell-culture system responsive to physiological concentrations of thyroid hormones. Science 181:1253-1255.
9. Lin K-h, Lin Y-W, Parkison C, Cheng S-y 1994 Stimulation of proliferation by 3,3′,5-triiodo-L-thyroine in poorly differentiated human hepatocarcinoma cells overexpressing β1 thyroid hormone receptor. Cancer Lett 85:189-194.
10. Lin K-h, Chen S-I, Zhu X-G, Shieh H-y, McPhie P, Cheng S-y 1997 The gene regulating activity of thyroid hormone nuclear receptors is modulated by cell-type specific factors. Biochem Biophys Res Commun 238:280-2847.
11. Meier C, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC, Menke JB, Hao E-H, Usala SJ, Bercu BB, Cheng S-y, Weintraub BD 1992 Variable transcriptional activity and ligand binding of mutant β1 3,3,5′-triiodo-L-thyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol 6:248-258.
12. Bhat MK, McPhie P, Ting YT, Zhu X-G, Cheng S-y 1995 The structure of the carboxyl-terminal region of thyroid hormone nuclear receptor and its role in hormone-dependent intermolecular interactions. Biochemistry 34: 10591-10599.
13. Fukuda T, Willingham MC, Cheng S-y 1988 Antipeptide antibodies recognize c-erbA and a related protein in human A431 carcinoma cells. Endocrinology 123:2646-2652.
14. Ting YT, Wong R, Cheng S-y 1997 Tissue-specific stabilization of the thyroid hormone β1 nuclear receptor by phosphorylation. J Biol Chem 272:4129-4134.
15. Lin K-H, Willingham MC, Liang C-M, Cheng S-y 1991 Intracellular distribution of the endogenous and transfected β form of thyroid hormone nuclear receptor visualized by the use of domain-specific monoclonal antibodies. Endocrinology 128:2601-2609.
16. Williams GR, Harney JW, Forman BM, Samuels, HH, Brent GA 1991 Oligomeric binding of T3 receptor is required for maximal T3 response. J Biol Chem 266:19636-19644.
17. Samuels HH, Shapiro LE 1976 Thyroid hormone stimulates de novo growth hormone synthesis in cultured GH1 cells: Evidence for the accumulation of a rate limiting RNA species in the induction process. Proc Natl Acad Sci USA 73: 3369-3373.
18. Schaufele F, West BL, Baxter JD 1992 Synergistic activation of the rat growth hormone promoter by Pit-1 and the thyroid hormone receptor. Mol Endocrinol 6:656-665.
19. Chang W, Zhou W, Theill LE, Baxter JD, Schaufele F 1996 An activation function in Pit-1 required selectively for synergistic transcription. J Biol Chem 271:17733-17738.
20. Lin K-h, Zhu X-G, Shieh HY, Hsu S-T, McPhie P, Cheng S-y 1996 Identification of naturally occurring dominant negative mutants of thyroid hormone α1 and β1 receptors in a human hepatocellular carcinoma cell line. Endocrinology 137:4073-1081.
21. Fang X, Hillgartner FB 1998 Cell-specific regulation of transcription of the malic enzyme gene: Characterization of cis-acting elements that modulate nuclear T3 receptor activity. Arch Biochem Biophys 349:138-152.